A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients

NCT05075304 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class

Stopped Due to the COVID-19 epidemic situation, the sponsor has decided to terminate the project.

Conditions

Interventions

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Collaborators